51 participants
Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2026-05-30
- Completion:
- 2028-05-30
Conditions
- Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Interventions
- DRUG
No Results Yet